nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Dactinomycin—germ cell cancer	0.2	0.319	CbGbCtD
Vecuronium—ABCB1—Vinblastine—germ cell cancer	0.126	0.2	CbGbCtD
Vecuronium—ABCB1—Cisplatin—germ cell cancer	0.115	0.183	CbGbCtD
Vecuronium—ABCB1—Etoposide—germ cell cancer	0.113	0.18	CbGbCtD
Vecuronium—CHRND—pericardium—germ cell cancer	0.103	0.341	CbGeAlD
Vecuronium—ABCB1—Methotrexate—germ cell cancer	0.0748	0.119	CbGbCtD
Vecuronium—SLC22A1—ganglion—germ cell cancer	0.0171	0.0568	CbGeAlD
Vecuronium—CHRNB1—eye—germ cell cancer	0.0115	0.0382	CbGeAlD
Vecuronium—CHRNA1—endocrine gland—germ cell cancer	0.00858	0.0284	CbGeAlD
Vecuronium—CHRNA1—head—germ cell cancer	0.00847	0.0281	CbGeAlD
Vecuronium—CHRNB1—medulla oblongata—germ cell cancer	0.00826	0.0274	CbGeAlD
Vecuronium—CHRNB1—adrenal gland—germ cell cancer	0.00764	0.0253	CbGeAlD
Vecuronium—CHRNB1—midbrain—germ cell cancer	0.00755	0.025	CbGeAlD
Vecuronium—CHRNB1—spinal cord—germ cell cancer	0.00736	0.0244	CbGeAlD
Vecuronium—CHRNB1—female gonad—germ cell cancer	0.00713	0.0236	CbGeAlD
Vecuronium—CHRNA2—endocrine gland—germ cell cancer	0.00712	0.0236	CbGeAlD
Vecuronium—CHRNA2—head—germ cell cancer	0.00703	0.0233	CbGeAlD
Vecuronium—SLC22A1—telencephalon—germ cell cancer	0.00661	0.0219	CbGeAlD
Vecuronium—CHRNB1—head—germ cell cancer	0.00654	0.0217	CbGeAlD
Vecuronium—CHRNB1—testis—germ cell cancer	0.00632	0.0209	CbGeAlD
Vecuronium—CHRNA2—cerebellum—germ cell cancer	0.00627	0.0208	CbGeAlD
Vecuronium—CHRNA1—brain—germ cell cancer	0.00614	0.0203	CbGeAlD
Vecuronium—CHRNB1—cerebellum—germ cell cancer	0.00584	0.0193	CbGeAlD
Vecuronium—CHRNA2—brain—germ cell cancer	0.0051	0.0169	CbGeAlD
Vecuronium—CHRNB1—brain—germ cell cancer	0.00474	0.0157	CbGeAlD
Vecuronium—CHRNB1—lymph node—germ cell cancer	0.00458	0.0152	CbGeAlD
Vecuronium—ABCB1—blood vessel—germ cell cancer	0.0044	0.0146	CbGeAlD
Vecuronium—SLC22A1—endocrine gland—germ cell cancer	0.00417	0.0138	CbGeAlD
Vecuronium—SLC22A1—head—germ cell cancer	0.00412	0.0136	CbGeAlD
Vecuronium—SLC22A1—brain—germ cell cancer	0.00299	0.00989	CbGeAlD
Vecuronium—ABCB1—trigeminal ganglion—germ cell cancer	0.00272	0.009	CbGeAlD
Vecuronium—ABCB1—embryo—germ cell cancer	0.00262	0.00869	CbGeAlD
Vecuronium—Respiratory failure—Ifosfamide—germ cell cancer	0.00233	0.0338	CcSEcCtD
Vecuronium—ABCB1—retina—germ cell cancer	0.00232	0.00769	CbGeAlD
Vecuronium—Apnoea—Etoposide—germ cell cancer	0.00213	0.0309	CcSEcCtD
Vecuronium—ABCB1—telencephalon—germ cell cancer	0.00213	0.00707	CbGeAlD
Vecuronium—ABCB1—decidua—germ cell cancer	0.00202	0.0067	CbGeAlD
Vecuronium—ABCB1—gonad—germ cell cancer	0.00178	0.0059	CbGeAlD
Vecuronium—ABCB1—uterus—germ cell cancer	0.00177	0.00586	CbGeAlD
Vecuronium—ABCB1—pituitary gland—germ cell cancer	0.00174	0.00576	CbGeAlD
Vecuronium—ABCB1—medulla oblongata—germ cell cancer	0.00168	0.00556	CbGeAlD
Vecuronium—Bronchospasm—Bleomycin—germ cell cancer	0.00165	0.0239	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—germ cell cancer	0.00156	0.0226	CcSEcCtD
Vecuronium—ABCB1—adrenal gland—germ cell cancer	0.00155	0.00514	CbGeAlD
Vecuronium—ABCB1—midbrain—germ cell cancer	0.00153	0.00508	CbGeAlD
Vecuronium—ABCB1—bone marrow—germ cell cancer	0.0015	0.00498	CbGeAlD
Vecuronium—ABCB1—spinal cord—germ cell cancer	0.0015	0.00495	CbGeAlD
Vecuronium—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00148	0.0214	CcSEcCtD
Vecuronium—ABCB1—female gonad—germ cell cancer	0.00145	0.0048	CbGeAlD
Vecuronium—Bronchospasm—Ifosfamide—germ cell cancer	0.00141	0.0205	CcSEcCtD
Vecuronium—Face oedema—Cisplatin—germ cell cancer	0.00138	0.02	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00136	0.0196	CcSEcCtD
Vecuronium—ABCB1—endocrine gland—germ cell cancer	0.00135	0.00446	CbGeAlD
Vecuronium—ABCB1—head—germ cell cancer	0.00133	0.0044	CbGeAlD
Vecuronium—ABCB1—testis—germ cell cancer	0.00128	0.00425	CbGeAlD
Vecuronium—Apnoea—Methotrexate—germ cell cancer	0.00128	0.0185	CcSEcCtD
Vecuronium—Flushing—Bleomycin—germ cell cancer	0.00125	0.0181	CcSEcCtD
Vecuronium—ABCB1—cerebellum—germ cell cancer	0.00119	0.00393	CbGeAlD
Vecuronium—Erythema—Bleomycin—germ cell cancer	0.00117	0.017	CcSEcCtD
Vecuronium—Flushing—Dactinomycin—germ cell cancer	0.00117	0.0169	CcSEcCtD
Vecuronium—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00113	0.0164	CcSEcCtD
Vecuronium—Bronchospasm—Etoposide—germ cell cancer	0.00112	0.0162	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—germ cell cancer	0.0011	0.016	CcSEcCtD
Vecuronium—Erythema—Dactinomycin—germ cell cancer	0.00109	0.0158	CcSEcCtD
Vecuronium—Cardiac disorder—Ifosfamide—germ cell cancer	0.00107	0.0155	CcSEcCtD
Vecuronium—Flushing—Ifosfamide—germ cell cancer	0.00107	0.0155	CcSEcCtD
Vecuronium—Angiopathy—Ifosfamide—germ cell cancer	0.00104	0.0151	CcSEcCtD
Vecuronium—Immune system disorder—Ifosfamide—germ cell cancer	0.00104	0.015	CcSEcCtD
Vecuronium—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00104	0.015	CcSEcCtD
Vecuronium—Erythema—Ifosfamide—germ cell cancer	0.001	0.0145	CcSEcCtD
Vecuronium—Connective tissue disorder—Cisplatin—germ cell cancer	0.000975	0.0141	CcSEcCtD
Vecuronium—ABCB1—brain—germ cell cancer	0.000963	0.00319	CbGeAlD
Vecuronium—Anaphylactic shock—Bleomycin—germ cell cancer	0.000957	0.0138	CcSEcCtD
Vecuronium—ABCB1—lymph node—germ cell cancer	0.00093	0.00308	CbGeAlD
Vecuronium—Flushing—Cisplatin—germ cell cancer	0.000921	0.0133	CcSEcCtD
Vecuronium—Cardiac disorder—Cisplatin—germ cell cancer	0.000921	0.0133	CcSEcCtD
Vecuronium—Angioedema—Ifosfamide—germ cell cancer	0.000915	0.0132	CcSEcCtD
Vecuronium—Immune system disorder—Cisplatin—germ cell cancer	0.000896	0.013	CcSEcCtD
Vecuronium—Mediastinal disorder—Cisplatin—germ cell cancer	0.000894	0.0129	CcSEcCtD
Vecuronium—Hypotension—Bleomycin—germ cell cancer	0.000894	0.0129	CcSEcCtD
Vecuronium—Erythema—Cisplatin—germ cell cancer	0.000864	0.0125	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000847	0.0123	CcSEcCtD
Vecuronium—Cardiac disorder—Etoposide—germ cell cancer	0.000843	0.0122	CcSEcCtD
Vecuronium—Flushing—Etoposide—germ cell cancer	0.000843	0.0122	CcSEcCtD
Vecuronium—Hypersensitivity—Vinblastine—germ cell cancer	0.000834	0.0121	CcSEcCtD
Vecuronium—Angiopathy—Etoposide—germ cell cancer	0.000825	0.0119	CcSEcCtD
Vecuronium—Immune system disorder—Etoposide—germ cell cancer	0.000821	0.0119	CcSEcCtD
Vecuronium—Mediastinal disorder—Etoposide—germ cell cancer	0.000819	0.0119	CcSEcCtD
Vecuronium—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000818	0.0118	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000813	0.0118	CcSEcCtD
Vecuronium—Nervous system disorder—Ifosfamide—germ cell cancer	0.000802	0.0116	CcSEcCtD
Vecuronium—Skin disorder—Ifosfamide—germ cell cancer	0.000794	0.0115	CcSEcCtD
Vecuronium—Hypotension—Ifosfamide—germ cell cancer	0.000764	0.0111	CcSEcCtD
Vecuronium—Urticaria—Bleomycin—germ cell cancer	0.00076	0.011	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00073	0.0106	CcSEcCtD
Vecuronium—Anaphylactic shock—Cisplatin—germ cell cancer	0.000705	0.0102	CcSEcCtD
Vecuronium—Hypersensitivity—Bleomycin—germ cell cancer	0.000705	0.0102	CcSEcCtD
Vecuronium—Nervous system disorder—Cisplatin—germ cell cancer	0.000691	0.01	CcSEcCtD
Vecuronium—Tachycardia—Cisplatin—germ cell cancer	0.000688	0.00995	CcSEcCtD
Vecuronium—Skin disorder—Cisplatin—germ cell cancer	0.000685	0.00991	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000669	0.00968	CcSEcCtD
Vecuronium—Hypotension—Cisplatin—germ cell cancer	0.000659	0.00953	CcSEcCtD
Vecuronium—Hypersensitivity—Dactinomycin—germ cell cancer	0.000657	0.00951	CcSEcCtD
Vecuronium—Urticaria—Ifosfamide—germ cell cancer	0.000649	0.0094	CcSEcCtD
Vecuronium—Anaphylactic shock—Etoposide—germ cell cancer	0.000646	0.00934	CcSEcCtD
Vecuronium—Tachycardia—Etoposide—germ cell cancer	0.00063	0.00912	CcSEcCtD
Vecuronium—Skin disorder—Etoposide—germ cell cancer	0.000627	0.00908	CcSEcCtD
Vecuronium—Hypotension—Etoposide—germ cell cancer	0.000603	0.00873	CcSEcCtD
Vecuronium—Rash—Bleomycin—germ cell cancer	0.000603	0.00873	CcSEcCtD
Vecuronium—Dermatitis—Bleomycin—germ cell cancer	0.000603	0.00872	CcSEcCtD
Vecuronium—Hypersensitivity—Ifosfamide—germ cell cancer	0.000602	0.00872	CcSEcCtD
Vecuronium—Rash—Dactinomycin—germ cell cancer	0.000563	0.00814	CcSEcCtD
Vecuronium—Hypersensitivity—Cisplatin—germ cell cancer	0.000519	0.00751	CcSEcCtD
Vecuronium—Rash—Ifosfamide—germ cell cancer	0.000515	0.00746	CcSEcCtD
Vecuronium—Dermatitis—Ifosfamide—germ cell cancer	0.000515	0.00745	CcSEcCtD
Vecuronium—Urticaria—Etoposide—germ cell cancer	0.000513	0.00742	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—germ cell cancer	0.000505	0.00731	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—germ cell cancer	0.000494	0.00715	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—germ cell cancer	0.000492	0.00712	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—germ cell cancer	0.000491	0.0071	CcSEcCtD
Vecuronium—Hypersensitivity—Etoposide—germ cell cancer	0.000476	0.00688	CcSEcCtD
Vecuronium—Erythema—Methotrexate—germ cell cancer	0.000474	0.00686	CcSEcCtD
Vecuronium—Rash—Cisplatin—germ cell cancer	0.000444	0.00643	CcSEcCtD
Vecuronium—Dermatitis—Cisplatin—germ cell cancer	0.000444	0.00643	CcSEcCtD
Vecuronium—Rash—Etoposide—germ cell cancer	0.000407	0.00589	CcSEcCtD
Vecuronium—Dermatitis—Etoposide—germ cell cancer	0.000407	0.00589	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000401	0.0058	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—germ cell cancer	0.000387	0.0056	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—germ cell cancer	0.000379	0.00549	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—germ cell cancer	0.000376	0.00544	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—germ cell cancer	0.000361	0.00523	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—germ cell cancer	0.000307	0.00445	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—germ cell cancer	0.000285	0.00412	CcSEcCtD
Vecuronium—Rash—Methotrexate—germ cell cancer	0.000244	0.00353	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—germ cell cancer	0.000244	0.00353	CcSEcCtD
